Lv11
75 积分 2022-04-21 加入
Immune checkpoint therapy—current perspectives and future directions
9个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
9个月前
已完结
Inflammation: the incubator of the tumor microenvironment
10个月前
已完结
Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient
10个月前
已完结
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
10个月前
已完结
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
10个月前
已完结
Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma
1年前
已完结
Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer
1年前
已完结
18F-FDG PET-CT在评估局部晚期非小细胞肺癌预后中的应用
1年前
已完结
[The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection]
1年前
已完结
皖公网安备34019202002308
